...
首页> 外文期刊>Journal of cellular biochemistry. >Quantitative proteome analysis of multidrug resistance in human ovarian cancer cell line.
【24h】

Quantitative proteome analysis of multidrug resistance in human ovarian cancer cell line.

机译:人卵巢癌细胞系中多药耐药性的定量蛋白质组分析。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In order to understand the molecular mechanisms of multidrug resistance (MDR) in ovarian cancer, we employed the proteomic approach of isobaric tags for relative and absolute quantification (iTRAQ), followed by LC-MS/MS, using the cisplatin-resistant COC1/DDP cell line and its parental COC1 cell line as a model. A total number of 28 proteins differentially expressed were identified, and then the differential expression levels of partially identified proteins were confirmed by Western blot analysis and/or real-time RT-PCR. Furthermore, the association of PKM2 and HSPD1, two differentially expressed proteins, with MDR were analyzed, and the results showed that they could contribute considerably to the cisplatin resistance in ovarian cancer cell. The differential expression proteins could be classified into eight categories based on their functions, that is, calcium binding proteins, chaperones, extracellular matrix, proteins involved in drug detoxification or repair of DNA damage, metabolic enzymes, transcription factor, proteins related to cellular structure and proteins relative to signal transduction. These data will be valuable for further study of the mechanisms of MDR in the ovarian cancer.
机译:为了了解卵巢癌多药耐药性(MDR)的分子机制,我们采用了等压标签的蛋白质组学方法对相对和绝对定量(iTRAQ),然后使用顺铂耐药的COC1 / DDP进行LC-MS / MS细胞系及其亲本COC1细胞系为模型。鉴定出总共28种差异表达的蛋白质,然后通过蛋白质印迹分析和/或实时RT-PCR确认部分鉴定的蛋白质的差异表达水平。此外,分析了两种差异表达的蛋白质PKM2和HSPD1与MDR的关联,结果表明它们可以大大促进卵巢癌细胞的顺铂耐药性。根据它们的功能,差异表达蛋白可以分为八类,即钙结合蛋白,伴侣蛋白,细胞外基质,参与药物排毒或修复DNA损伤的蛋白,代谢酶,转录因子,与细胞结构和相关的蛋白。与信号转导有关的蛋白质。这些数据将为进一步研究卵巢癌中MDR的机制提供有价值的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号